Determining acceptance and perceptions of chemotherapy dose banding in an ambulatory cancer centre
Authors:
- 13 June 2023
- journal article
- research article
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 30 (3) , 474-487
Abstract
Introduction: Despite the advantages of dose banding (DB) and numerous plans to adopt this practice, uptake of DB is still poor. As opinions of healthcare professionals were deemed essential in DB's acceptance, this study surveyed key stakeholders to determine the acceptance, facilitators, and barriers of DB in chemotherapy to improve its implementation. Methods: A cross-sectional study at the National Cancer Centre Singapore, involving physicians, nurses, and pharmacy staff, was conducted in February 2022. The Theory of Planned Behaviour was adapted to design a survey questionnaire to obtain the acceptance, facilitators, and barriers of DB. Additional questions on maximum acceptable dose variance and essential criteria for selecting drugs for DB were included. Results: A total of 93 participants responded, with a mean 9.75 ± 7.37 years of clinical experience. Less than half have heard of DB while few had prior experience. Drug cost was the top selection criteria for DB, followed by toxicity, therapeutic index, frequency of use and drug wastage. Acceptance rate of DB was 41.9%, with majority agreeing to use DB in various drugs but to determine patient suitability before usage. Being greatly affected by subjective norms, having a positive outlook for DB's impacts, and no effect on toxicity significantly influenced acceptance. Conclusion: Prior to implementing DB at the institutional level, educational training addressing concerns over toxicity, and providing technological support can help improve acceptance. Future studies can involve patients’ perspectives and more institutions for greater diversity in opinions.Keywords
This publication has 39 references indexed in Scilit:
- Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agentsBritish Journal of Cancer, 2012
- Comparisons of Health Care Systems in the United States, Germany and CanadaMateria Socio Medica, 2012
- Guidelines for the practical stability studies of anticancer drugs: A European consensus conferenceAnnales Pharmaceutiques Françaises, 2011
- Dose standardisation of anticancer drugsInternational Journal of Clinical Pharmacy, 2011
- Cost savings from dose rounding of biologic anticancer agents in adultsJournal of Oncology Pharmacy Practice, 2010
- A National Survey Investigating UK Prescribers' Opinions on Chemotherapy Dosing and ‘Dose-Banding’Clinical Oncology, 2009
- A sequential temperature cycling study for the investigation of carboplatin infusion stability to facilitate `dose-banding'Journal of Oncology Pharmacy Practice, 2007
- Dose-banding of carboplatin: rationale and proposed banding schemeJournal of Oncology Pharmacy Practice, 2007
- The Theory of Planned Behavior: A Review of its Applications to Health-Related BehaviorsAmerican Journal of Health Promotion, 1996
- The theory of planned behaviorOrganizational Behavior and Human Decision Processes, 1991